265 related articles for article (PubMed ID: 12881528)
1. Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites.
Dixelius J; Makinen T; Wirzenius M; Karkkainen MJ; Wernstedt C; Alitalo K; Claesson-Welsh L
J Biol Chem; 2003 Oct; 278(42):40973-9. PubMed ID: 12881528
[TBL] [Abstract][Full Text] [Related]
2. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
3. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
[TBL] [Abstract][Full Text] [Related]
4. Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity.
Alam A; Herault JP; Barron P; Favier B; Fons P; Delesque-Touchard N; Senegas I; Laboudie P; Bonnin J; Cassan C; Savi P; Ruggeri B; Carmeliet P; Bono F; Herbert JM
Biochem Biophys Res Commun; 2004 Nov; 324(2):909-15. PubMed ID: 15474514
[TBL] [Abstract][Full Text] [Related]
5. The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration.
Holmqvist K; Cross MJ; Rolny C; Hägerkvist R; Rahimi N; Matsumoto T; Claesson-Welsh L; Welsh M
J Biol Chem; 2004 May; 279(21):22267-75. PubMed ID: 15026417
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns.
Jeltsch M; Karpanen T; Strandin T; Aho K; Lankinen H; Alitalo K
J Biol Chem; 2006 Apr; 281(17):12187-95. PubMed ID: 16505489
[TBL] [Abstract][Full Text] [Related]
8. The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man.
Baldwin ME; Catimel B; Nice EC; Roufail S; Hall NE; Stenvers KL; Karkkainen MJ; Alitalo K; Stacker SA; Achen MG
J Biol Chem; 2001 Jun; 276(22):19166-71. PubMed ID: 11279005
[TBL] [Abstract][Full Text] [Related]
9. Structural determinants of growth factor binding and specificity by VEGF receptor 2.
Leppänen VM; Prota AE; Jeltsch M; Anisimov A; Kalkkinen N; Strandin T; Lankinen H; Goldman A; Ballmer-Hofer K; Alitalo K
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2425-30. PubMed ID: 20145116
[TBL] [Abstract][Full Text] [Related]
10. Signal transduction by VEGF receptor-1 wild type and mutant proteins.
Ito N; Huang K; Claesson-Welsh L
Cell Signal; 2001 Nov; 13(11):849-54. PubMed ID: 11583921
[TBL] [Abstract][Full Text] [Related]
11. The presence of a single tyrosine residue at the carboxyl domain of vascular endothelial growth factor receptor-2/FLK-1 regulates its autophosphorylation and activation of signaling molecules.
Meyer RD; Dayanir V; Majnoun F; Rahimi N
J Biol Chem; 2002 Jul; 277(30):27081-7. PubMed ID: 12023952
[TBL] [Abstract][Full Text] [Related]
12. Identification of VEGF receptor-2 tyrosine phosphorylation sites involved in VEGF-mediated endothelial platelet-activating factor synthesis.
Rechka A; Neagoe PE; Gratton JP; Sirois MG
Can J Physiol Pharmacol; 2010 Oct; 88(10):968-76. PubMed ID: 20962896
[TBL] [Abstract][Full Text] [Related]
13. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
[TBL] [Abstract][Full Text] [Related]
14. Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation.
Leppänen VM; Tvorogov D; Kisko K; Prota AE; Jeltsch M; Anisimov A; Markovic-Mueller S; Stuttfeld E; Goldie KN; Ballmer-Hofer K; Alitalo K
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):12960-5. PubMed ID: 23878260
[TBL] [Abstract][Full Text] [Related]
15. Activation of vascular endothelial growth factor receptor-3 and its downstream signaling promote cell survival under oxidative stress.
Wang JF; Zhang X; Groopman JE
J Biol Chem; 2004 Jun; 279(26):27088-97. PubMed ID: 15102829
[TBL] [Abstract][Full Text] [Related]
16. VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis.
Zhang L; Zhou F; Han W; Shen B; Luo J; Shibuya M; He Y
Cell Res; 2010 Dec; 20(12):1319-31. PubMed ID: 20697430
[TBL] [Abstract][Full Text] [Related]
17. VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy.
Rahimi N
Front Biosci; 2006 Jan; 11():818-29. PubMed ID: 16146773
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity.
Kawamura H; Li X; Harper SJ; Bates DO; Claesson-Welsh L
Cancer Res; 2008 Jun; 68(12):4683-92. PubMed ID: 18559514
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.
Rahimi N
Exp Eye Res; 2006 Nov; 83(5):1005-16. PubMed ID: 16713597
[TBL] [Abstract][Full Text] [Related]
20. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]